Cambridge Investment Research Advisors’s Ingles Markets IMKTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$379K Sell
4,275
-6,228
-59% -$557K ﹤0.01% 2997
2026
Q1
$944K Hold
10,503
﹤0.01% 2223
2025
Q4
$720K Buy
+10,503
New +$763K ﹤0.01% 2393
2024
Q1
Sell
-2,822
Closed -$244K 3358
2023
Q4
$244K Sell
2,822
-111
-4% -$9.04K ﹤0.01% 2760
2023
Q3
$221K Sell
2,933
-461
-14% -$37.1K ﹤0.01% 2730
2023
Q2
$281K Sell
3,394
-566
-14% -$48.7K ﹤0.01% 2585
2023
Q1
$351K Buy
3,960
+75
+2% +$6.96K ﹤0.01% 2347
2022
Q4
$375K Buy
3,885
+795
+26% +$74.6K ﹤0.01% 2253
2022
Q3
$245K Buy
3,090
+111
+4% +$10.1K ﹤0.01% 2538
2022
Q2
$258K Buy
2,979
+98
+3% +$8.91K ﹤0.01% 2516
2022
Q1
$257K Sell
2,881
-72
-2% -$6.12K ﹤0.01% 2670
2021
Q4
$255K Buy
+2,953
New +$225K ﹤0.01% 2682

Other funds holding IMKTA

Cambridge Investment Research Advisors's IMKTA Position: Q2 2026 in Review

Cambridge Investment Research Advisors reduced its Ingles Markets (IMKTA) stake by 59% in Q2 2026, selling an estimated $557K and leaving 4,275 shares worth $379K. The position accounts for ﹤0.01% of the portfolio, ranked #2997.

Cambridge Investment Research Advisors first reported a position in IMKTA in Q4 2021 and has held it in 12 quarters since. The position peaked at $944K in Q1 2026. 41 funds tracked by Wall St. Rank hold IMKTA as of Q2 2026.

  • Cambridge Investment Research Advisors held 4,275 shares of Ingles Markets worth $379K as of Q2 2026.
  • Cambridge Investment Research Advisors sold 6,228 Ingles Markets shares in Q2 2026, an estimated $557K.
  • Ingles Markets made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #2997 holding.
  • Cambridge Investment Research Advisors first reported a position in Ingles Markets in Q4 2021 and has held it in 12 quarters since.
  • Cambridge Investment Research Advisors's Ingles Markets position peaked at $944K in Q1 2026.
  • 41 funds tracked by Wall St. Rank held Ingles Markets as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.